NewsBenzinga트루이스트 증권, 리프트 투자의견 ‘보유’ 유지···목표주가 18달러로 상향 트루이스트 증권, 리프트 투자의견 ‘보유’ 유지···목표주가 18달러로 상향 Benzinga 2026.11.06 18:15 (GMT+0) Open on Benzinga Other news Canaccord Genuity Maintains Buy on Redwire, Lowers Price Target to $13 RBC Capital Maintains Outperform on Verastem, Lowers Price Target to $18 Canaccord Genuity Maintains Buy on NuScale Power, Lowers Price Target to $11 RBC Capital Maintains Outperform on Veeva Systems, Raises Price Target to $365 Canaccord Genuity Maintains Buy on TransMedics Group, Raises Price Target to $120 RBC Capital Maintains Outperform on VSE, Raises Price Target to $225
